Specificity of Vigabatrin for the GABAergic System in Human Epilepsy |
| |
Authors: | Paavo J Riekkinen Asia Pitkanen Aarne Ylinen Juhani Sivenius Toivo Halonen |
| |
Affiliation: | Department of Neurology, University Central Hospital ofKuopio, Kuopio, Finland |
| |
Abstract: | Summary: The therapeutic action of vigabatrin (gamma vinyl GABA, GVG) has been reported to be mediated by GABAergic neurotransmission. In the present study, we evaluated different neurotransmitter systems in the cerebrospinal fluid (CSF) of patients with complex partial epilepsy, before and during GVG treatment. The markers of the GABAergic system (free GABA, total GABA, homocarnosine) showed a two- to threefold elevation. There was also an increase in glycine during the 6 months of GVG treatment. In contrast, we did not find any constant CSF changes in either excitatory amino acids or in markers of the cholinergic (acetylcholinesterase), dopaminergic (homovanillic acid), serotonergic (5-hydroxyin-doleacetic acid), or peptidergic (somatostatin, prolactin, β-endorphin) systems. This finding (except an elevation in glycine) was in agreement with previous studies which suggest a specific action of GVG on the GABAergic system. The role of glycine in antiepileptic efficacy of GVG needs further evaluation. |
| |
Keywords: | Anticonvulsants Gamma vinyl GABA Neurotransmitters Amino acids Glycine |
|
|